vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and DULUTH HOLDINGS INC. (DLTH). Click either name above to swap in a different company.
DULUTH HOLDINGS INC. is the larger business by last-quarter revenue ($114.9M vs $62.1M, roughly 1.8× Cytek Biosciences, Inc.). DULUTH HOLDINGS INC. runs the higher net margin — -8.8% vs -70.9%, a 62.1% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs -9.6%). Cytek Biosciences, Inc. produced more free cash flow last quarter ($-1.8M vs $-8.9M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs -31.6%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Duluth Holdings Inc., which primarily sells goods through its Duluth Trading Company brand, is an American workwear and accessories company.
CTKB vs DLTH — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $114.9M |
| Net Profit | $-44.1M | $-10.1M |
| Gross Margin | 52.9% | 53.8% |
| Operating Margin | -9.0% | -7.7% |
| Net Margin | -70.9% | -8.8% |
| Revenue YoY | 8.1% | -9.6% |
| Net Profit YoY | -557.1% | 64.6% |
| EPS (diluted) | — | $-0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $114.9M | ||
| Q3 25 | $52.3M | $131.7M | ||
| Q2 25 | $45.6M | $102.7M | ||
| Q1 25 | $41.5M | $241.3M | ||
| Q4 24 | $57.5M | $127.1M | ||
| Q3 24 | $51.5M | $141.6M | ||
| Q2 24 | $46.6M | $116.7M | ||
| Q1 24 | $44.9M | $245.6M |
| Q4 25 | $-44.1M | $-10.1M | ||
| Q3 25 | $-5.5M | $1.3M | ||
| Q2 25 | $-5.6M | $-15.3M | ||
| Q1 25 | $-11.4M | $-5.6M | ||
| Q4 24 | $9.6M | $-28.2M | ||
| Q3 24 | $941.0K | $-2.0M | ||
| Q2 24 | $-10.4M | $-7.9M | ||
| Q1 24 | $-6.2M | $6.4M |
| Q4 25 | 52.9% | 53.8% | ||
| Q3 25 | 52.7% | 54.7% | ||
| Q2 25 | 52.3% | 52.0% | ||
| Q1 25 | 48.6% | 44.1% | ||
| Q4 24 | 58.5% | 52.3% | ||
| Q3 24 | 56.3% | 52.3% | ||
| Q2 24 | 54.6% | 52.8% | ||
| Q1 24 | 51.3% | 48.2% |
| Q4 25 | -9.0% | -7.7% | ||
| Q3 25 | -17.6% | 1.8% | ||
| Q2 25 | -23.3% | -12.0% | ||
| Q1 25 | -36.1% | -1.8% | ||
| Q4 24 | 5.2% | -17.4% | ||
| Q3 24 | -8.2% | -1.1% | ||
| Q2 24 | -18.3% | -7.7% | ||
| Q1 24 | -23.9% | 3.6% |
| Q4 25 | -70.9% | -8.8% | ||
| Q3 25 | -10.5% | 1.0% | ||
| Q2 25 | -12.2% | -14.9% | ||
| Q1 25 | -27.5% | -2.3% | ||
| Q4 24 | 16.8% | -22.2% | ||
| Q3 24 | 1.8% | -1.4% | ||
| Q2 24 | -22.4% | -6.7% | ||
| Q1 24 | -13.8% | 2.6% |
| Q4 25 | — | $-0.29 | ||
| Q3 25 | — | $0.04 | ||
| Q2 25 | — | $-0.45 | ||
| Q1 25 | — | $-0.17 | ||
| Q4 24 | — | $-0.84 | ||
| Q3 24 | — | $-0.06 | ||
| Q2 24 | — | $-0.24 | ||
| Q1 24 | — | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $8.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $160.6M |
| Total Assets | $461.5M | $468.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $8.2M | ||
| Q3 25 | $93.3M | $5.7M | ||
| Q2 25 | $75.5M | $8.6M | ||
| Q1 25 | $95.3M | $3.3M | ||
| Q4 24 | $98.7M | $9.3M | ||
| Q3 24 | $162.3M | $9.8M | ||
| Q2 24 | $177.9M | $6.8M | ||
| Q1 24 | $168.8M | $32.2M |
| Q4 25 | $341.7M | $160.6M | ||
| Q3 25 | $378.6M | $170.0M | ||
| Q2 25 | $377.6M | $167.9M | ||
| Q1 25 | $379.6M | $182.7M | ||
| Q4 24 | $395.7M | $188.1M | ||
| Q3 24 | $385.5M | $215.7M | ||
| Q2 24 | $389.1M | $218.4M | ||
| Q1 24 | $392.6M | $222.8M |
| Q4 25 | $461.5M | $468.0M | ||
| Q3 25 | $494.9M | $433.8M | ||
| Q2 25 | $493.3M | $463.7M | ||
| Q1 25 | $482.6M | $452.4M | ||
| Q4 24 | $499.5M | $533.1M | ||
| Q3 24 | $491.2M | $488.6M | ||
| Q2 24 | $483.7M | $471.4M | ||
| Q1 24 | $492.1M | $491.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $-6.7M |
| Free Cash FlowOCF − Capex | $-1.8M | $-8.9M |
| FCF MarginFCF / Revenue | -2.9% | -7.8% |
| Capex IntensityCapex / Revenue | 1.6% | 2.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $1.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $-6.7M | ||
| Q3 25 | $-3.9M | $32.0M | ||
| Q2 25 | $108.0K | $-56.5M | ||
| Q1 25 | $-125.0K | $41.2M | ||
| Q4 24 | $2.0M | $-41.1M | ||
| Q3 24 | $13.2M | $16.6M | ||
| Q2 24 | $6.2M | $-33.7M | ||
| Q1 24 | $4.0M | $69.7M |
| Q4 25 | $-1.8M | $-8.9M | ||
| Q3 25 | $-4.6M | $29.8M | ||
| Q2 25 | $-1.5M | $-57.8M | ||
| Q1 25 | $-974.0K | $38.7M | ||
| Q4 24 | $1.1M | $-43.7M | ||
| Q3 24 | $12.2M | $15.0M | ||
| Q2 24 | $5.2M | $-35.2M | ||
| Q1 24 | $3.4M | $60.6M |
| Q4 25 | -2.9% | -7.8% | ||
| Q3 25 | -8.7% | 22.6% | ||
| Q2 25 | -3.2% | -56.3% | ||
| Q1 25 | -2.3% | 16.0% | ||
| Q4 24 | 1.9% | -34.4% | ||
| Q3 24 | 23.7% | 10.6% | ||
| Q2 24 | 11.0% | -30.2% | ||
| Q1 24 | 7.6% | 24.7% |
| Q4 25 | 1.6% | 2.0% | ||
| Q3 25 | 1.3% | 1.7% | ||
| Q2 25 | 3.5% | 1.3% | ||
| Q1 25 | 2.0% | 1.0% | ||
| Q4 24 | 1.6% | 2.1% | ||
| Q3 24 | 2.0% | 1.2% | ||
| Q2 24 | 2.3% | 1.3% | ||
| Q1 24 | 1.3% | 3.7% |
| Q4 25 | — | — | ||
| Q3 25 | — | 25.40× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 10.86× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
DLTH
| Sales Channel Directly To Consumer | $67.4M | 59% |
| Sales Channel Through Intermediary | $47.4M | 41% |
